Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody‐mediated rejection: a pilot study

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0012|29|5|439-446

ISSN： 0902-0063

Source： CLINICAL TRANSPLANTATION (ELECTRONIC), Vol.29, Iss.5, 2015-05, pp. : 439-446

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progressive Multifocal Leukoencephalopathy in a Heart Transplant Recipient Following Rituximab Therapy for Antibody‐Mediated Rejection

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 13, Iss. 4, 2013-04 ,pp. : 1075-1079

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eculizumab Salvage Therapy for Antibody‐Mediated Rejection in a Desensitization‐Resistant Intestinal Re‐Transplant Patient

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 7, 2015-07 ,pp. : 1995-2000

John Wiley & Sons Inc

Access to resources Recommend Favorite

Microarray Diagnosis of Antibody‐Mediated Rejection in Kidney Transplant Biopsies: An International Prospective Study (INTERCOM)

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 13, Iss. 11, 2013-11 ,pp. : 2865-2874

John Wiley & Sons Inc

Access to resources Recommend Favorite

Older kidney transplant patients experience less antibody‐mediated rejection: a retrospective study of patients with mild to moderate sensitization

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 12, 2015-12 ,pp. : 1090-1097

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inflammatory Cell Burden and Phenotype in Endomyocardial Biopsies With Antibody‐Mediated Rejection (AMR): A Multicenter Pilot Study From the AECVP

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 2, 2015-02 ,pp. : 526-534

John Wiley & Sons Inc

Access to resources Recommend Favorite